CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Dan Vahdat

Cofounder, Huma

Search every verified Dan Vahdat interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Dan Vahdat, founder and CEO of healthcare technology company Huma, has recently discussed the company's growth to a $1 billion valuation and its platform approach to healthcare innovation. In podcast appearances, he described Huma's strategy of building configurable software that can be adapted across diseases and markets, rather than focusing on single use cases. He also spoke about the company's work in remote patient monitoring and decentralized clinical trials, noting partnerships with organizations including AstraZeneca and deployments in hospitals and clinics across multiple countries. Vahdat attributed part of Huma's success to persistence in sharing his vision, which he compared to planting seeds that later grew when conditions became favorable. Vahdat has also commented on European competitiveness and healthcare policy. At the FII Priority Europe event in 2025, he proposed five executive orders for European leaders, including cutting regulations by 50%, accelerating energy initiatives, and simplifying talent acquisition. He argued that Europe had lost a culture of hard work and needed to create environments where companies could hire quickly. In other interviews, he discussed the role of AI in healthcare, saying it could help shift care from reactive to proactive models, and expressed views on topics such as the blurring line between diagnostics and therapeutics, the importance of partnerships in healthcare, and his belief that entrepreneurs are essential to national economies. He also shared personal reflections on his Iranian background and the challenges of building a company in Europe.

Recent appearances

  • Making Your Own Luck: Huma’s Journey to its Billion Dollar Valuation with Founder & CEO, Dan Vahd...

    March 18, 2026 · 📺 Brandpie

    What does it mean to make your own luck? Dan Vahdat’s persistence planted the seeds in people’s minds that healthcare can change, and that Huma is the business to lead the revolution. He saw through his vision until it rained, and those seeds became growth - Huma’s $1bn valuation is driven by a bold embrace of calculated serendipity. Dan challenges the standard CEO playbook, navigating the pivot points of Huma’s journey without all the answers, leaning on his razor-sharp instinct.  After all, in his eyes, perfect things are made by imperfect people… If Dan’s leadership style resonate…

    Watch on YouTube ↗

  • FII Priority Europe 25: Dan Vahdat - Founder & CEO, Huma

    March 10, 2026 · 📺 FII Institute

    Dan Vahdat, Founder & CEO of Huma, discusses how Europe can regain its former glory by implementing five executive orders, including reducing regulations, accelerating energy initiatives, and fostering talent acquisition. He emphasizes the importance of creating a single European NASDAQ and reducing taxes on tech and AI innovators. Vahdat also highlights the potential of AI in transforming healthcare from reactive to proactive, aiming for longer, healthier lives. He shares his vision of democratizing healthcare, making it as accessible as a Google map. The discussion touches on the challenge…

    Watch on YouTube ↗

  • The Decisions Behind Huma: The Platform Approach to Healthcare Innovation with Dan Vahdat

    March 05, 2026 · 📺 CEO Pajama Time

    Enjoy this behind-the-scenes look at how bold vision, stubborn persistence, and platform thinking are revolutionizing healthcare, one disease, one regulation, one market at a time. Dan Vahdat, CEO of Huma, shares the story behind creating a platform that scales across diseases, regulations, and markets without losing sight of the big vision. In this episode: The origin story: From Johns Hopkins lab nerd to healthcare disruptor Why building a platform beats focusing on single-use cases The regulatory secret sauce: Configurable software as a medical device Common pitfalls: Do's and don’ts of vi…

    Watch on YouTube ↗

  • The man behind Huma ($1B Health Company)

    September 22, 2025 · 📺 TERRA API

    The first Iranian entrepreneur to build a company worth over $1B in Europe, ⁠Dan Vahdat⁠   / danvahdat  , founder of ⁠Huma⁠, is joining ⁠Kyriakos Eleftheriou   / kyriakosel   ⁠, founder of ⁠Terra API⁠ They discuss: 00:00 - Intro 02:10 - Communicating with @EmmanuelMacron and @kmitsotakis 08:55 - Why are Greece and Persia not empires today 13:40 - How the best people look like 18:30 - Short-term vs long-term thinking 24:27 - Dropping out of PhD 26:57 - The first months of Huma 32:00 - Early days 32:27 - 'I never had the ego of being turned down' 34:00 - First customers 37:21 - How to price ex…

    Watch on YouTube ↗

  • Ep128: Dan Vahdat founder of HealthTech unicorn Huma. Solving hard problems and the value of naivety

    September 01, 2025 · 📺 HealthTech Hour

    Dan Vahdat is the founder and CEO of Huma, a healthcare AI company valued at over $1 billion, dedicated to accelerating the adoption of digital solutions in healthcare and research. In this episode he speaks to Steve Roest, founder and CEO of PocDoc on his journey to creating Huma, his philosophies on growing complex companies in complex industries and on why he split Huma into units with their own CEO. Huma’s technology has powered more than 1,000 clinical trials and is used in 4,500 hospitals and clinics across the US and beyond. Its platform has screened, triaged, and engaged over 50 mill…

    Watch on YouTube ↗

  • Huma’s CEO Dan Vahdat on Nadia's Lab

    June 03, 2025 · 📺 Nadia's Lab

    Is this the future of medicine? 👨‍⚕️📱 In this episode of Nadia’s Lab, I sit down with Dan Vahdat, the founder and CEO of Huma, the $1B AI-driven health tech company revolutionizing how we deliver care, monitor patients remotely, and run clinical trials. From virtual wards and decentralized trials to AI-powered apps used by the NHS, Dan shares how Huma is changing healthcare — and what’s coming next. We also explore whether doctors will ever be replaced by AI, how digital platforms are doubling hospital capacity, and what the next wave of breakthroughs might look like in global healthcare. This…

    Watch on YouTube ↗

  • EP 175 - Dan Vahdat, CEO of Huma | Digital Medicine: A Dream Dan Vahdat Turned into Reality

    April 25, 2025 · 📺 طبقه 16

    ​Dhanush Vahdat, founder and CEO of Huma, is transforming healthcare with the help of artificial intelligence. His startup, which recently raised over $200 million in funding and is valued at over $1 billion, is working with thousands of hospitals and clinics around the world. Lack of ongoing monitoring of patients after discharge. Under his leadership, Huma has developed a platform that enables remote patient monitoring and decentralized clinical trials, and works with over 4,500 hospitals and clinics worldwide. In this episode of the podcast, we explore Dan’s professional journey, the challe…

    Watch on YouTube ↗

  • EP 119 - Dan Vahdat | زندگی طولانی‌تر، پربارتر با مراقبت دیجیتال

    December 15, 2023 · 📺 طبقه 16

    در این قسمت از پادکست طبقه ۱۶، با دن وحدت، بنیان‌گذار و مدیرعامل شرکت هوما گپ زدم. دن درباره‌ی چرایی تأسیس هوما و هدفش برای ایجاد تحول در حوزه سلامت با استفاده از تکنولوژی، برای بالاتر بردن کیفیت زندگی انسان‌ها صحبت کرد. این شرکت که در سال ۲۰۱۱ در لندن تأسیس شده، حالا با بیش از ۴۵۰ کارمند در بیش از ۲۰ کشور فعالیت می‌کنه و تا به امروز ۲۵۰ میلیون دلار جذب سرمایه کرده. In this episode, I sit down with Dan Vahdat, founder and CEO of Huma, who talks about the why behind founding Huma and his aim to revolutionize healthcare through technology. Founded in and London in 2011, the company now operate…

    Watch on YouTube ↗

  • #120 Billion $ Healthtech 'Soonicorn': Jony Ive and Big Pharma's Lessons — Dan Vahdat (CEO Huma)

    June 26, 2023 · 📺 Dr Mustafa Sultan

    Huma is about to reach a 1 billion dollar valuation, and is thriving — when other digital health companies are dying. But what’s their secret sauce? Dan Vahdat is the Johns Hopkins dropout — who meticulously studied the successful business practices of big pharma, and using these, has created the 'soonicorn' digital health company that’s about to take over the world of remote patient monitoring and decentralised clinical trials. 0:00 Intro 1:11 Focusing on one big thing is bullsh*t 6:33 Lessons from Jony Ive 10:02 Healthtech infrastructure play 16:04 'Ownership is everything' discussion 20:…

    Watch on YouTube ↗

  • Health Innovators – Abby Staible and Dan Vahdat

    March 03, 2023 · 📺 pharmaphorum media limited

    AstraZeneca has been working with UK startup Huma for several years to explore ways to improve the experience of patients across their patient journey using digital technology. At the HealthTech X Digitisation of Pharma summit in London last week, pharmaphorum Editor in Chief Jonah Comstock had a chance to sit down with the leaders on both sides of that partnership.

    Watch on YouTube ↗

  • Heard at HLTH: Huma

    January 04, 2023 · 📺 MedCity News

    Dan Vahdat, Huma CEO and founder, shares his company’s unique journey to support remote patient monitoring. Although Huma’s business is global, the American reimbursement model offers an advantage and opportunities for building a presence in the U.S. market. He also shares the importance of a strong user interface and onboarding strategy to improve patient engagement, and identifies goals for 2023, including collaborations in asthma, COPD, and oncology. Visit https://www.huma.com/ for more information.

    Watch on YouTube ↗

  • Entrepreneurs and the COVID-19 effect #TheAgenda

    February 22, 2021 · 📺 CGTN Europe

    On #TheAgenda, Stephen Cole talks to Dan Vahdat, Founder and CEO of Huma, an A.I. business designed to democratize healthcare. He shares how he came up with his business idea and how the pandemic has transformed his operation. 📲 Follow CGTN Europe on social media and other platforms👇🏼 https://stories.cgtneurope.tv/follow-...

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →